Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > How to Survive the Perils of Executive Decisioning

Tags

  • drugs
  • would
  • product
  • combination products
  • companies involved

  • Links

  • Your Job
  • Creating Sacred Space
  • Why Testimonials Are The Only Proof You've Got?
  • Digg It - How to Survive the Perils of Executive Decisioning

    Senior executives who rise to the C-suite do so largely based upon their ability to consistently make sound decisions. However while it
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    may take years of solid decision making to reach the boardroom it often times only takes one bad decision to fall from the ivory tower.
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    The reality is that in today’s competitive business world an executive is only as good as his/her last decision.

    Nobody is immune to ba
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    d decisioning…We have all made bad decisions whether we like to admit it or not. I have either been a principal owner or senior executi
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ve since I was in my mid 20’s and have generally been highly regarded for my decision making ability. That being said, I have also made
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    my fair share of regrettable decisions. When I reflect back upon the poor decisions I’ve made it’s not that I wasn’t capable of making t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    he correct decision, but for whatever reason I failed to use sound decisioning methodology.

    The complexity of the current business land
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    scape combined with ever increasing expectations of performance and the speed at which decisions must be made are a potential recipe for
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    disaster for today’s executive unless a defined methodology for decisioning is put into place. If you incorporate the following metrics
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    into your decisioning framework you will minimize the chances of making a bad decision:

    1. Perform a Situation Analysis: What is motiv
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ating the need for a decision? Who will the decision impact? What data, analytics, research or supporting information do you have to val
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    idate your decision?

    2. Subject your Decision to Public Scrutiny: There are no private decisions…Sooner or later the details surroundin
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    g any decision will likely come out. If your decision were printed on the front page of the newspaper how would you feel? What would you
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    r family think of your decision? How would your shareholders and employees feel about your decision? Have you sought counsel and/or feed
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    back before making your decision?

    3. Conduct a Cost/Benefit Analysis: Do the potential benefits derived from the decision justify the e
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    xpected costs? What if the costs exceed projections and the benefits fall short of projections?

    4. Assess the Risk/Reward Ratio: What a
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    re all the possible rewards and when contrasted with all the potential risks and are the odds in your favor or against you?

    Decisions c
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    an, and usually will, make or break an executive. Those executives that avoid making decisions for fear of making a bad decision will ra
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    rely rise above mid-management, and those that make decisions just for the sake of making a decision will likely not last long. If you
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    develop the appropriate blend of a bias to action with an analytical approach to decisioning your stock as an executive will surely rise


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/22648/diggit-How-to-Survive-the-Perils-of-Executive-Decisioning.html">How to Survive the Perils of Executive Decisioning</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/22648/diggit-How-to-Survive-the-Perils-of-Executive-Decisioning.html]How to Survive the Perils of Executive Decisioning[/url]

    Related Articles:

    Should a Small Business Have a Brochure?

    Resume Recycling: Good For The Planet - Not So Good For Your Career

    Get A New Job - Career Choices

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com